Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations

Liviu Klein; Christopher M. O'Connor; Wendy A. Gattis; Manuela Zampino; Leonardo De Luca; Antonio Vitarelli; Francesco Fedele; Mihai Gheorghiade

doi:10.1016/s0002-9149(02)03336-2

Keywords

MedicineHeart failureCardiologyInternal medicineValsartanMetoprololBisoprololDigoxinAmlodipineAtrial fibrillationLisinoprilCarvedilolAmiodaroneRamiprilAngiotensin-converting enzymeBlood pressure

Affiliated Institutions

Related Publications

A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure

Jay N. Cohn , Gianni Tognoni

Valsartan significantly reduces the combined end point of mortality and morbidity and improves clinical signs and symptoms in patients with heart failure, when added to prescrib...

2001 New England Journal of Medicine 3079 citations

Clinical trials update and cumulative meta‐analyses from the American College of Cardiology: WATCH, SCD‐HeFT, DINAMIT, CASINO, INSPIRE, STRATUS‐US, RIO‐Lipids and cardiac resynchronisation therapy in heart failure

John G.F. Cleland , Justin Ghosh , Nick Freemantle +4 more

Abstract This article continues a series of reports on recent research developments in the field of heart failure. Key presentations made at the American College of Cardiology m...

2004 European Journal of Heart Failure 245 citations

The Effect of Digoxin on Mortality and Morbidity in Patients with Heart Failure

The Digitalis Investigation Group

Digoxin did not reduce overall mortality, but it reduced the rate of hospitalization both overall and for worsening heart failure. These findings define more precisely the role ...

1997 New England Journal of Medicine 2957 citations

The CARE‐HF study (CArdiac REsynchronisation in Heart Failure study): rationale, design and end‐points

John G.F. Cleland , Claude Daubert , Erland Erdmann +5 more

Abstract Background: Cardiac resynchronisation is a promising new intervention for patients with heart failure, left ventricular systolic dysfunction and ventricular dyssynchron...

2001 European Journal of Heart Failure 319 citations

Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure

Jay N. Cohn , Donald Archibald , Susan Ziesche +15 more

To evaluate the effects of vasodilator therapy on mortality among patients with chronic congestive heart failure, we randomly assigned 642 men with impaired cardiac function and...

1986 New England Journal of Medicine 2404 citations

Publication Info

Year: 2003
Type: review
Volume: 91
Issue: 9
Pages: 18-40
Citations: 126
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

126

OpenAlex

Cite This

APA Style

                            
                                
                                    Liviu Klein, 
                                
                                    Christopher M. O'Connor, 
                                
                                    Wendy A. Gattis
                                
                                et al.
                            
                            (2003). 
                            Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations. 
                            The American Journal of Cardiology
                            , 91
                            (9)
                            , 18-40.
                            https://doi.org/10.1016/s0002-9149(02)03336-2
                        

Identifiers

DOI: 10.1016/s0002-9149(02)03336-2